[go: up one dir, main page]

AU1630288A - Substituted compounds, processes for their preparation and uses thereof - Google Patents

Substituted compounds, processes for their preparation and uses thereof

Info

Publication number
AU1630288A
AU1630288A AU16302/88A AU1630288A AU1630288A AU 1630288 A AU1630288 A AU 1630288A AU 16302/88 A AU16302/88 A AU 16302/88A AU 1630288 A AU1630288 A AU 1630288A AU 1630288 A AU1630288 A AU 1630288A
Authority
AU
Australia
Prior art keywords
processes
preparation
substituted compounds
substituted
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU16302/88A
Inventor
Rainer Endermann
Karl Georg Metzger
Gunter Schmidt
Hans-Joachim Zeiler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU1630288A publication Critical patent/AU1630288A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Aiming, Guidance, Guns With A Light Source, Armor, Camouflage, And Targets (AREA)
  • Saccharide Compounds (AREA)

Abstract

Vinylcephalosporins of the formula (I) <IMAGE> in which the symbols R<1>, R<2>, R<3>, R<4> and R<5> have the meaning given in the description.
AU16302/88A 1987-05-26 1988-05-16 Substituted compounds, processes for their preparation and uses thereof Abandoned AU1630288A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3717663 1987-05-26
DE3717663 1987-05-26
DE3734005 1987-10-08
DE19873734005 DE3734005A1 (en) 1987-05-26 1987-10-08 SUBSTITUTED VINYLCEPHALOSPORINS, THE METHOD OF MANUFACTURING THEIR PRODUCTS AND THEIR USE AS A MEDICINAL PRODUCT

Publications (1)

Publication Number Publication Date
AU1630288A true AU1630288A (en) 1988-12-01

Family

ID=25856023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16302/88A Abandoned AU1630288A (en) 1987-05-26 1988-05-16 Substituted compounds, processes for their preparation and uses thereof

Country Status (15)

Country Link
EP (1) EP0292806B1 (en)
JP (1) JPH0645628B2 (en)
KR (1) KR880013925A (en)
CN (1) CN1020732C (en)
AT (1) ATE113598T1 (en)
AU (1) AU1630288A (en)
CA (1) CA1340424C (en)
DE (2) DE3734005A1 (en)
DK (1) DK284588A (en)
ES (1) ES2061550T3 (en)
FI (1) FI882444A7 (en)
HU (1) HU205938B (en)
IL (1) IL86479A (en)
NO (1) NO170936C (en)
PT (1) PT87563B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3734004A1 (en) * 1987-05-26 1988-12-15 Bayer Ag SUBSTITUTED VINYLCEPHALOSPORINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT
DE3933934A1 (en) * 1989-10-03 1991-04-11 Bayer Ag METHOD FOR PRODUCING 7-AMINO-3 - ((Z) -1-PROPEN-1-YL) -3-CEPHEM-4-CARBONIC ACID
AT399876B (en) * 1992-02-05 1995-08-25 Biochemie Gmbh Purificn. of 7-amino-3-((z)-1-propen-1-yl)-3 -cephem-4-carboxylic acid - useful in prodn. of broadband antibiotics
JP2825655B2 (en) 1992-02-05 1998-11-18 バイオケミ・ゲゼルシヤフト・エム・ベー・ハー Purification method of 3-cephem-4-carboxylic acid derivative
CA2935651A1 (en) 2007-10-09 2009-04-16 Gladius Pharmaceuticals Corporation Broad spectrum beta-lactamase inhibitors
EP2968352B1 (en) 2013-03-12 2018-09-26 Gladius Pharmaceuticals Corporation Derivatized 3-styryl-cephalosporins

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769277A (en) * 1970-01-23 1973-10-30 Glaxo Lab Ltd Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group
US4255423A (en) * 1977-07-27 1981-03-10 Merck & Co., Inc. Cephalosporin compounds
US4390693A (en) * 1977-07-27 1983-06-28 Merck & Co., Inc. Cephalosporin compounds
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
DE3508258A1 (en) * 1985-03-08 1986-09-18 Bayer Ag, 5090 Leverkusen SS LACTAMANTIBIOTICS, METHOD FOR THE PRODUCTION AND THEIR USE AS AND IN MEDICINAL PRODUCTS
US4619925A (en) * 1985-11-08 1986-10-28 Bristol-Myers Company 3-Propenyl cephalosporin derivatives
JPS63126022A (en) * 1986-11-17 1988-05-30 Hitachi Ltd Display device
DE3734004A1 (en) * 1987-05-26 1988-12-15 Bayer Ag SUBSTITUTED VINYLCEPHALOSPORINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT

Also Published As

Publication number Publication date
EP0292806B1 (en) 1994-11-02
JPH0645628B2 (en) 1994-06-15
EP0292806A3 (en) 1990-10-17
NO170936B (en) 1992-09-21
DK284588A (en) 1988-11-27
CA1340424C (en) 1999-03-09
HUT48891A (en) 1989-07-28
NO170936C (en) 1993-01-06
NO882113D0 (en) 1988-05-13
PT87563B (en) 1992-09-30
NO882113L (en) 1988-11-28
HU205938B (en) 1992-07-28
FI882444A7 (en) 1988-11-27
DE3734005A1 (en) 1988-12-15
ES2061550T3 (en) 1994-12-16
DK284588D0 (en) 1988-05-25
EP0292806A2 (en) 1988-11-30
CN88103111A (en) 1988-12-28
DE3851979D1 (en) 1994-12-08
ATE113598T1 (en) 1994-11-15
FI882444A0 (en) 1988-05-24
JPS63307884A (en) 1988-12-15
IL86479A0 (en) 1988-11-15
KR880013925A (en) 1988-12-22
IL86479A (en) 1993-08-18
PT87563A (en) 1989-05-31
CN1020732C (en) 1993-05-19

Similar Documents

Publication Publication Date Title
AU584124B2 (en) Diarylacetylenes, their preparation and their use
GR3007513T3 (en)
ZA914133B (en) Preparation of substituted piperidines
WO1991001958A3 (en) 11β-ARYL-GONA-4,9-DIEN-3-ONES
CA2041831A1 (en) N-glycidyl compound
JPS6419066A (en) Dihydropyridineamides
EP0218970A3 (en) Chiral rhodium-diphosphine complexes for asymmetrical hydrogenation
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
AU1630288A (en) Substituted compounds, processes for their preparation and uses thereof
AU1264488A (en) Substituted pyridine-2,4-dicarboxylic acid derivatives, processes for their preparation, the use thereof and medicaments based on these compounds
AU2240388A (en) Azachromane derivatives
AU3188893A (en) Alpha-aryl-alpha-hydroxy-beta-imidazolinyl-propionamides
AU548410B2 (en) 5-6-dihydro-11-alkylene-morphanthridin-6-one
DK0551653T3 (en) Enantiomeric pure cis-2-oxa-5,8-diazabicyclo (4.3.0) nonanes and process for their preparation
EP0418990A3 (en) 13-bromo and 13,14-dibromo ergoline, their preparation and their use
ES8703847A1 (en) Sulfonyl-guanidinopyrimidine derivatives.
EP0529444A3 (en) 2-arylpropenic acids and their utilisation in the preparation of 5-ketoprofen
ES8703855A1 (en) Sulfonyl-guanidinotriazine derivatives.
AU2859792A (en) 5,6-dihydro-dibenz(b,e)azepine-6,11-dione-11-oximes
AU7463487A (en) 3-substituted 1-(2-halogenoalkoxy-benzenesulphonyl)-3- heteroaryl-(thio) ureas
ES8800666A1 (en) 1,4-Dihydropyridine derivatives, process for their preparation and their use in medicaments.
AU4863993A (en) Tetrahydroindazolone pharmaceutical compositions
ES8606298A1 (en) 1,4-Dihydropyrazines, process for their preparation and their use in medicines.